APRI (Aprinoia Therapeutics) Float Percentage Of Total Shares Outstanding: 93.61% (As of Jun. 27, 2026)


What is Aprinoia Therapeutics Float Percentage Of Total Shares Outstanding?

Aprinoia Therapeutics APRI Float Percentage Of Total Shares Outstanding is 93.61% as of Jun. 27, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aprinoia Therapeutics's float shares is 25.14 Mil. Aprinoia Therapeutics's total shares outstanding is 26.86 Mil. Aprinoia Therapeutics's float percentage of total shares outstanding is 93.61%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aprinoia Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aprinoia Therapeutics's Institutional Ownership is 0.00%.

Aprinoia Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Aprinoia Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=25.14/26.86
=93.61%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 93.61% mean?
Aprinoia Therapeutics (APRI) has a Float Percentage Of Total Shares Outstanding of 93.61% as of Jun. 27, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Aprinoia Therapeutics' current Float Percentage Of Total Shares Outstanding is 93.61%.
How does Aprinoia Therapeutics' Float Percentage Of Total Shares Outstanding compare to ?
Aprinoia Therapeutics' Float Percentage Of Total Shares Outstanding of 93.61% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Float Percentage Of Total Shares Outstanding is 93.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Float Percentage Of Total Shares Outstanding of 93.61%. The current Float Percentage Of Total Shares Outstanding is 93.61%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Float Percentage Of Total Shares Outstanding is 93.61% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.